These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35097007)

  • 1. Comparative Efficacy of Medical Treatments for Chronic Heart Failure: A Network Meta-Analysis.
    Xiang B; Yu Z; Zhou X
    Front Cardiovasc Med; 2021; 8():787810. PubMed ID: 35097007
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination pharmacotherapies for cardiac reverse remodeling in heart failure patients with reduced ejection fraction: A systematic review and network meta-analysis of randomized clinical trials.
    Bao J; Kan R; Chen J; Xuan H; Wang C; Li D; Xu T
    Pharmacol Res; 2021 Jul; 169():105573. PubMed ID: 33766629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Systematic Review and Network Meta-Analysis.
    Zafeiropoulos S; Farmakis IT; Milioglou I; Doundoulakis I; Gorodeski EZ; Konstantinides SV; Cooper L; Zanos S; Stavrakis S; Giamouzis G; Butler J; Giannakoulas G
    JACC Heart Fail; 2024 Apr; 12(4):616-627. PubMed ID: 37656079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiovascular outcomes of novel drugs as an addition to conventional triple therapy for heart failure with reduced ejection fraction (HFrEF): a network meta-analysis of randomised controlled trials.
    Suebsaicharoen T; Chunekamrai P; Yingchoncharoen T; Tansawet A; Issarawattana T; Numthavaj P; Thakkinstian A
    Open Heart; 2023 Nov; 10(2):. PubMed ID: 37940331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    Tang J; Wang P; Liu C; Peng J; Liu Y; Ma Q
    Chin Med J (Engl); 2024 May; ():. PubMed ID: 38811344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction.
    Tromp J; Ouwerkerk W; van Veldhuisen DJ; Hillege HL; Richards AM; van der Meer P; Anand IS; Lam CSP; Voors AA
    JACC Heart Fail; 2022 Feb; 10(2):73-84. PubMed ID: 34895860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fraction.
    Schupp T; Bertsch T; Reinhardt M; Abel N; Schmitt A; Lau F; Abumayyaleh M; Akin M; Weiß C; Weidner K; Behnes M; Akin I
    Eur J Prev Cardiol; 2024 Aug; 31(11):1347-1360. PubMed ID: 38513366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network meta-analysis of medical therapy efficacy in more than 90,000 patients with heart failure and reduced ejection fraction.
    De Marzo V; Savarese G; Tricarico L; Hassan S; Iacoviello M; Porto I; Ameri P
    J Intern Med; 2022 Aug; 292(2):333-349. PubMed ID: 35332595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of heart failure therapy in patients with mildly reduced ejection fraction: a network meta-analysis.
    Leite M; Sampaio F; Saraiva FA; Diaz SO; Barros AS; Fontes-Carvalho R
    ESC Heart Fail; 2023 Jun; 10(3):1822-1834. PubMed ID: 36896801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Traditional Heart Failure Therapies in Patients With Cardiac Amyloidosis and Heart Failure.
    Yan CL; Gallo RA; Vasquez Martinez M; Rivera Rodriguez B; Trujillo L; Thakkar Rivera N; Hoffman JE
    Am J Cardiol; 2023 Oct; 204():360-365. PubMed ID: 37573615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis.
    Burnett H; Earley A; Voors AA; Senni M; McMurray JJ; Deschaseaux C; Cope S
    Circ Heart Fail; 2017 Jan; 10(1):e003529. PubMed ID: 28087688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis.
    Komajda M; Böhm M; Borer JS; Ford I; Tavazzi L; Pannaux M; Swedberg K
    Eur J Heart Fail; 2018 Sep; 20(9):1315-1322. PubMed ID: 29806165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013-2020.
    Karlström P; Pivodic A; Dahlström U; Fu M
    Clin Res Cardiol; 2024 Sep; 113(9):1355-1368. PubMed ID: 39186181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis.
    Xiang B; Zhang R; Wu X; Zhou X
    JAMA Netw Open; 2022 Sep; 5(9):e2231963. PubMed ID: 36125813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Network Meta-Analysis.
    Sreenivasan J; Malik A; Khan MS; Lloji A; Hooda U; Aronow WS; Lanier GM; Pan S; Greene SJ; Murad MH; Michos ED; Cooper HA; Gass A; Gupta R; Desai NR; Mentz RJ; Frishman WH; Panza JA
    Cardiol Rev; 2024 Mar-Apr 01; 32(2):114-123. PubMed ID: 36576372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
    Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC
    JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review.
    Pascual-Figal D; Bayes-Genis A
    Front Cardiovasc Med; 2024; 11():1439696. PubMed ID: 39314771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.
    Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK
    Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in efficacy of pharmacological therapies in heart failure with reduced ejection fraction: a meta-analysis.
    Danielson C; Lileikyte G; Ouwerkerk W; S P Lam C; Erlinge D; Teng TK
    ESC Heart Fail; 2022 Aug; 9(4):2753-2761. PubMed ID: 35603531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.